Back to Results

Zepp Health Corp (ZEPP)

Featured in High-Beta Stocks

Zepp Health Corporation is the issuer associated with the NYSE-listed ZEPP depositary receipt for common stock. The company operates globally in the smart wearable and health technology space, focusing on products and digital tools designed to support health, fitness, and wellness tracking. Its consumer brands include Amazfit, Zepp Clarity, and Zepp Aura. Through its Zepp Digital Management Platform, which incorporates Zepp OS, AI chips, biometric sensors, and data algorithms, the company provides cloud-based insights and guidance based on user data. Zepp Health’s product range includes smart bands, watches, scales, rings, and related accessories, as well as smart hearable products, sportswear, home appliances, and smart watch accessories. It also offers Zepp Aura, a personalized sound health solution, along with Zepp Life and Zepp mobile apps that present charts and graphs for activity and biometric analysis. The company markets products in about 90 countries and was formerly known as Huami Corporation before adopting the Zepp Health Corporation name in February 2021. Founded in 2013, it is based in Gorinchem, the Netherlands.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-ZEPP
$7.03
26.7% Upside
Undervalued
$56.28
915.0% Upside
Bargain
Weak
—
—
—
0.0%
August 26, 2026
-2.1x
0.4x
0.3x
77.578 M
157.9 M
63.1%
41.7%
2.8
—
65.6%
Send a message
Valuation • Fair Value

Zepp Health Corp (NYSE-ZEPP) Fair Value by Valuation Model

Compare the primary fair value estimate for Zepp Health Corp (NYSE-ZEPP) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$7.03

Estimated upside of 26.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$7.03

Comparable-company valuation reference.

Analyst Price Target

$56.28

Analysts imply upside of 915.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Zepp Health Corp (NYSE-ZEPP) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Zepp Health Corp (NYSE-ZEPP)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

271.9 M

Current operating scale indicator.

Revenue Forecast

333.8 M

Forward revenue estimate.

EBITDA

-23.933 M

Current operating profitability reference.

EBITDA Forecast

10.015 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Zepp Health Corp (NYSE-ZEPP) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Zepp Health Corp (NYSE-ZEPP)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.46

No elevated caution signal from this screen.

Altman Z-Score

2.8

Intermediate risk zone.

FCF / Net Income

65.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Zepp Health Corp (NYSE-ZEPP). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Zepp Health Corp (NYSE-ZEPP)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 26, 2026

Days to Earnings

36

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Zepp Health Corp (NYSE-ZEPP), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Zepp Health Corp (NYSE-ZEPP) Stock Forecast & Technical Outlook

Review Zepp Health Corp (NYSE-ZEPP) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Zepp Health Corp (NYSE-ZEPP) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Zepp Health Corp (NYSE-ZEPP)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Zepp Health Corp (NYSE-ZEPP) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Zepp Health Corp (NYSE-ZEPP) Stock FAQ

Quick answers about Zepp Health Corp (NYSE-ZEPP) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$7.03
Estimated upside 26.7%
Valuation Rating
Undervalued
Estimated upside of 26.7%
Analyst Target
$56.28
Implied upside 915.0%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Zepp Health Corp (NYSE-ZEPP) is $7.03. This implies an estimated upside of 26.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 26.7% versus the current market price.

The available analyst price target for Zepp Health Corp (NYSE-ZEPP) is $56.28. The analyst target implies estimated upside of 915.0%.

The current financial health read for Zepp Health Corp (NYSE-ZEPP) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Zepp Health Corp (NYSE-ZEPP) is August 26, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Zepp Health Corp (NYSE-ZEPP) is -2.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Zepp Health Corp is 77.578 M.

The current enterprise value listed for Zepp Health Corp is 157.9 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Zepp Health Corp is NYSE-ZEPP, and the stock is listed on NYSE.

Zepp Health Corp (NYSE-ZEPP) is listed on NYSE.

The current debt-to-total-capital ratio listed for Zepp Health Corp is 63.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Zepp Health Corp is 41.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Electronic Equipment, Instruments & Components Stocks on NYSE View more

Amphenol Corporation (APH) Amphenol Corporation (APH)
Corning Incorporated (GLW) Corning Incorporated (GLW)
TE Connectivity Ltd (TEL) TE Connectivity Ltd (TEL)
Coherent Inc (COHR) Coherent Inc (COHR)
Keysight Technologies Inc (KEYS) Keysight Technologies Inc (KEYS)
Celestica Inc. (CLS) Celestica Inc. (CLS)
Jabil Circuit Inc (JBL) Jabil Circuit Inc (JBL)
Teledyne Technologies Incorporated (TDY) Teledyne Technologies Incorporated (TDY)
TD Synnex Corp (SNX) TD Synnex Corp (SNX)
Fabrinet (FN) Fabrinet (FN)
Arrow Electronics Inc (ARW) Arrow Electronics Inc (ARW)
Ralliant Corp (RAL) Ralliant Corp (RAL)
Ingram Micro Holding Ltd (INGM) Ingram Micro Holding Ltd (INGM)
Vishay Intertechnology Inc (VSH) Vishay Intertechnology Inc (VSH)
Badger Meter Inc (BMI) Badger Meter Inc (BMI)
Vontier Corp (VNT) Vontier Corp (VNT)
Mirion Technologies Inc (MIR) Mirion Technologies Inc (MIR)
Belden Inc (BDC) Belden Inc (BDC)
LG Display Co Ltd (LPL) LG Display Co Ltd (LPL)
Knowles Cor (KN) Knowles Cor (KN)
Crane NXT Co (CXT) Crane NXT Co (CXT)
Benchmark Electronics Inc (BHE) Benchmark Electronics Inc (BHE)
Rogers Corporation (ROG) Rogers Corporation (ROG)
CTS Corporation (CTS) CTS Corporation (CTS)